一种用于克服非小细胞肺癌治疗中抗原异质性的多靶向 CAR-T 细胞平台
A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer.
这些发现支持采用多靶点CAR-T 策略来应对NSCLC及可能其他实体瘤中的抗原异质性。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Tumor cell-intrinsic circular RNA circFNDC3B attenuates CD8(+) T cells infiltration in non-small cell lung cancer.
Tumor cell-intrinsic circular RNA circFNDC3B attenuates CD8(+) T cells infiltration in non-small cell lung cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
肿瘤浸润性CD8+ T细胞对抗肿瘤免疫至关重要,并与患者生存呈正相关。然而,调控CD8+T细胞浸润的机制仍未完全阐明,尤其是涉及环状RNA(circRNA)的机制。
在本研究中,我们表征了四对非小细胞肺癌(NSCLC)正常与肿瘤组织中circRNA的表达谱,并鉴定出circFNDC3B——一种来源于纤连蛋白III型结构域包含3B(FNDC3B)基因外显子2和3的环状转录本——在NSCLC组织中显著上调。机制研究揭示,circFNDC3B直接结合转录因子II-I(TFII-I),形成RNA-蛋白复合物,竞争性破坏TFII-I与STAT1之间的相互作用。这种隔离作用消除了CXCL10和CXCL11的转录激活,这两种趋化因子是调控CD8+T细胞趋化募集的关键因子。
因此,CXCL10/11表达的降低显著损害了CD8+T细胞向肿瘤微环境的浸润。与此一致,小鼠同源circFndc3b的表达与肿瘤中CD8+T细胞浸润呈负相关。
我们的研究揭示了一条关键的circRNA介导的调控轴,其中circFNDC3B通过抑制趋化因子依赖的CD8+T细胞募集来阻碍抗肿瘤免疫,将circFNDC3B定位为增强NSCLC中CD8+T细胞介导的抗肿瘤反应的潜在治疗靶点。
Tumor-infiltrating CD8 + T cells are critical for anti-tumor immunity and positively associated with patient survival.
However, the mechanisms governing CD8 + T cell infiltration remain incompletely elucidated, particularly those involving circular RNAs (circRNAs). In this study, we characterized circRNA expression profiles in four paired normal and tumor tissues of non-small-cell lung cancer (NSCLC) and identified that circFNDC3B, a circular transcript derived from exons 2 and 3 of the fibronectin type III domain containing 3B (FNDC3B) gene, as significantly upregulated in NSCLC tissues.
Mechanistic investigations revealed that circFNDC3B directly binds to transcription factor II-I (TFII-I), forming an RNA-protein complex that competitively disrupts the interaction between TFII-I and STAT1. This sequestration abrogates the transcriptional activation of CXCL10 and CXCL11, two critical chemokines governing CD8 + T cell chemoattraction.
Consequently, reduced CXCL10/11 expression significantly impairs CD8 + T cell infiltration into the tumor microenvironment. Consistently, the murine ortholog circFndc3b expression exhibits an inverse correlation with CD8 + T cell infiltration in tumors.
Our study uncovers a crucial circRNA-mediated regulatory axis wherein circFNDC3B impedes anti-tumor immunity by suppressing chemokine-dependent CD8 + T cell recruitment, positioning circFNDC3B as a potential therapeutic target to enhance CD8 + T cell-mediated anti-tumor responses in NSCLC.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。